| Particulars |
|
|
|
| Company Name
| Glenmark Pharmaceuticals Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
28.22 |
B.V. (₹) |
868.30 |
| Sales(₹ Cr.) |
9,010.54 |
NP (₹ Cr.) |
1,744.30 |
| NP Var% |
22.00 |
Div% |
250.00 |
| CPS(₹) |
69.60 |
EPS (₹) |
61.80 |
| Traded Value(₹ Lakhs) |
17,963.41 |
52 Week High |
2,286.00 |
| 52 Week Low |
1,275.00 |
Price BSE |
2,182.00 |
| Price NSE |
2,181.00 |
Market Capital (₹ Cr.) |
61,563.52 |
| P/C Ratio |
31.40 |
P/E Ratio |
35.30 |
| Price Vs.BV |
2.51 |
|
| Latest Quarter |
| Year End |
202503 |
Sales (₹ Cr.) |
1,909.94 |
| NP(₹ Cr.) |
268.56 |
NP Var % |
-68.00 |
| Trailing Twelve Months |
| Year End |
202503 |
Sales |
8,273.06 |
| OPM |
22.69 |
NP |
1,895.02 |
| NP Var% |
22.40 |
EPS |
61.81 |
| PE |
35.29 |
|
|